Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.
about
Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of ligand-independe ...... ically-modified antibody DN30.
@en
type
label
Inhibition of ligand-independe ...... ically-modified antibody DN30.
@en
prefLabel
Inhibition of ligand-independe ...... ically-modified antibody DN30.
@en
P2093
P2860
P50
P1433
P1476
Inhibition of ligand-independe ...... ically-modified antibody DN30.
@en
P2093
Cristina Basilico
Cristina Chiriaco
Fiorella Petronzelli
Lara Fontani
P2860
P304
P356
10.1016/J.MOLONC.2015.05.007
P577
2015-06-05T00:00:00Z